Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes

International Journal of Epidemiology

Volumn 42, Issue 1, 2013, Pages 270-280

  Alexeeff, Stacey E ^a   Baccarelli, Andrea A ^a,b   Halonen, Jaana ^a,c   Coull, Brent A ^a   Wright, Robert O ^a,d   Tarantini, Letizia ^b   Bollati, Valentina ^b   Sparrow, David ^e   Vokonas, Pantel ^e   Schwartz, Joel ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bayesian model; Blood pressure; DNA methylation; Epigenetics; Inflammation

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2;

AGING; BAYESIAN ANALYSIS; BLOOD; DNA; ELDERLY POPULATION; GENE EXPRESSION; GENETICS; HETEROGENEITY; METHYLATION; NUMERICAL MODEL;

ADULT; AGED; ARTICLE; BAYES THEOREM; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DNA METHYLATION; DNA SEQUENCE; DNA STRUCTURE; EPIGENETICS; GENETIC ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; LONG INTERSPERSED NUCLEAR ELEMENT 1; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROPOSON; STRUCTURAL EQUATION MODELING; SYSTOLIC BLOOD PRESSURE; TRANSPOSON;

AGED; AGED, 80 AND OVER; AGING; BASE SEQUENCE; BAYES THEOREM; BIOLOGICAL MARKERS; BLOOD PRESSURE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; RETROELEMENTS;

EID: 84875629238     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys220     Document Type: Article

References (66)

1. Fields LE, Burt VL, Cutler JA et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398-404.
2. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009;21:243-51.
3. Bollati V, Baccarelli A, Hou L et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007;67:876-80.
4. Kazazian HH Jr, Moran JV. The impact of L1 retrotransposons on the human genome. Nat Genet 1998;19:19-24.
5. Carnell AN, Goodman JI. The long (LINEs) and the short (SINEs) of it: altered methylation as a precursor to toxicity. Toxicol Sci 2003;75:229-35.
6. Wallace N, Wagstaff BJ, Deininger PL, Roy-Engel AM. LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene 2008;419:1-6.
7. Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 2006;310:211-50.
8. Chen JM, Stenson PD, Cooper DN, Ferec C. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 2005;117:411-27.
9. Belancio VP, Deininger PL, Roy-Engel AM. LINE dancing in the human genome: transposable elements and disease. Genome Med 2009;1:97.
10. Ostertag EM, Kazazian HH Jr. Biology of mammalian L1 retrotransposons. Annual review of genetics 2001;35:501-38.
11. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004;429:268-74.
12. Ergun S, Buschmann C, Heukeshoven J et al. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem 2004;279: 27753-63.
13. Sciamanna I, Landriscina M, Pittoggi C et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 2005;24:3923-31.
14. Feinberg AP, Tycko B. The history of cancer epigenetics. Nature Rev Cancer 2004;4:143-53.
15. Irizarry RA, Ladd-Acosta C, Wen B et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009;41:178-86.
16. Pogribny IP, Pogribna M, Christman JK, James SJ. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. Cancer Res 2000;60:588-94.
17. Ishida K, Kobayashi T, Ito S et al. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 2012;83:917-25.
18. Zou B, Chim CS, Zeng H et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006;131:1835-43.
19. Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Int J Inflam 2011;2011:514623.
20. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002;106: 820-25.
21. Rana JS, Arsenault BJ, Despres JP et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J 2011;32:336-44.
22. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-97.
23. Danesh J, Whincup P, Walker M et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
24. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol 2009;507:3-20.
25. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 2008;79:1514-19.
26. Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res 2011;90:9-17.
27. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008;58:2686-93.
28. Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ. Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 2010;14:1225-40.
29. Turunen MP, Aavik E, Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 2009;1790:886-91.
30. Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 2009;66:2249-61.
31. Hiltunen MO, Yla-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol 2003;23:1750-53.
32. Yideng J, Jianzhong Z, Ying H et al. Homocysteinemediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 2007;26:603-11.
33. Hiltunen MO, Turunen MP, Hakkinen TP et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002;7:5-11.
34. Castro R, Rivera I, Struys EA et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003;49:1292-96.
35. Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist 1966;6: 179-84.
36. Baccarelli A, Wright RO, Bollati V et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009;179:572-78.
37. Bollati V, Schwartz J, Wright R et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009;130:234-39.
38. Sanchez B, Budtz-Jorgensen E, Ryan L, Hu H. Structural equation models: a review with applications to environmental epidemiology. JAMA 2005;100:1443-55.
39. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 2006;1:515-33.
40. Thierry-Mieg D, Thierry-Mieg J. AceView: integrative annotation of cDNA-supported genes in human, mouse, rat, worm and Arabidopsis. http://www.ncbi.nlm.nih.gov/ IEB/Research/Acembly (28 December 2012, date last accessed).
41. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007;4:444-54.
42. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009;296:H1-H12.
43. Liu V, Huang PL. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 2008;77:18-29.
44. McLaren JE, Ramji DP. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009;20:125-35.
45. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008;79:360-76.
46. Nakamura T, Ebihara I, Takahashi T et al. Increased interleukin 6 mRNA expression by peripheral blood T cells from patients with IgA nephropathy. Autoimmunity 1993;15:171-79.
47. Wannamethee SG, Whincup PH, Rumley A, Lowe GD. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 2007;5:1637-43.
48. Kuningas M, Mooijaart SP, Slagboom PE, Westendorp RG, van Heemst D. Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study. Biogerontology 2006;7:231-38.
49. Rosmond R, Holm G. A 5-year follow-up study of 3 polymorphisms in the human glucocorticoid receptor gene in relation to obesity, hypertension, and diabetes. J Cardiometab Syndr 2008;3:132-35.
50. Newman PE. Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Med Hypotheses 1999; 53:421-24.
51. Lund G, Andersson L, Lauria M et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004;279:29147-54.
52. Kim M, Long TI, Arakawa K et al. DNA methylation as a biomarker for cardiovascular disease risk. PloS one 2010;5: e9692.
53. Yang AS, Estecio MR, Doshi K et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004;32: e38.
54. Weisenberger DJ, Campan M, Long TI et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005;33:6823-36.
55. Bollati V, Fabris S, Pegoraro V et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis 2009;30:1330-35.
56. Szpakowski S, Sun X, Lage JM et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene 2009;448:151-67.
57. Choi JY, James SR, Link PA et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009;30:1889-97.
58. Hou L, Wang H, Sartori S et al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer 2010;127:1866-74.
59. Li TH, Schmid CW. Differential stress induction of individual Alu loci: implications for transcription and retrotransposition. Gene 2001;276: 135-41.
60. Tarantini L, Bonzini M, Apostoli P et al. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environmental health perspectives 2009;117:217-22.
61. Pavanello S, Bollati V, Pesatori AC et al. Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer 2009;125:1692-97.
62. Wright RO, Schwartz J, Wright RJ et al. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect 2010;118:790-95.
63. Garcia-Perez JL, Doucet AJ, Bucheton A, Moran JV, Gilbert N. Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res 2007;17:602-11.
64. Han JS, Boeke JD. LINE-1 retrotransposons: modulators of quantity and quality of mammalian gene expression? Bioessays 2005;27:775-84.
65. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
66. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13.